AlphaFold predicted structure
FGF12 · P61328

Mean pLDDT
77.3/ 100
Confident
243 residues
Confidence breakdown
- Very high(≥ 90)54%
- Confident(70–90)9%
- Low(50–70)18%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
fibroblast growth factor 12
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMitochondrial disorders
genetic developmental and epileptic encephalopathy
neurodegenerative disease
Epileptic encephalopathy
undetermined early-onset epileptic encephalopathy
Seizure
cervical carcinoma
insomnia
brain injury
pyogenic granuloma
atherosclerosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Fibroblast growth factor 12
Involved in nervous system development and function. Involved in the positive regulation of voltage-gated sodium channel activity. Promotes neuronal excitability by elevating the voltage dependence of neuronal sodium channel SCN8A fast inactivation
FGF12 · P61328

Mean pLDDT
77.3/ 100
Confident
243 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0